AU2019285375B2 - Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane - Google Patents

Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane Download PDF

Info

Publication number
AU2019285375B2
AU2019285375B2 AU2019285375A AU2019285375A AU2019285375B2 AU 2019285375 B2 AU2019285375 B2 AU 2019285375B2 AU 2019285375 A AU2019285375 A AU 2019285375A AU 2019285375 A AU2019285375 A AU 2019285375A AU 2019285375 B2 AU2019285375 B2 AU 2019285375B2
Authority
AU
Australia
Prior art keywords
prebiotic
sugarcane
fibre material
fibre
phytonutrient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019285375A
Other languages
English (en)
Other versions
AU2019285375A1 (en
Inventor
Gordon Edwards
Rajamaran Eri
Tanvi Sandesh Shinde
Roger Anthony Stanley
Kent John Neil Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tasmania
Original Assignee
University of Tasmania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018902145A external-priority patent/AU2018902145A0/en
Application filed by University of Tasmania filed Critical University of Tasmania
Publication of AU2019285375A1 publication Critical patent/AU2019285375A1/en
Application granted granted Critical
Publication of AU2019285375B2 publication Critical patent/AU2019285375B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2019285375A 2018-06-15 2019-06-12 Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane Active AU2019285375B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2018902145A AU2018902145A0 (en) 2018-06-15 Preparation for the Treatment of Inflammatory Bowel Disease using a Whole Plant Fibre Extract from Sugarcane
AU2018902145 2018-06-15
PCT/AU2019/050604 WO2019237152A1 (en) 2018-06-15 2019-06-12 Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane

Publications (2)

Publication Number Publication Date
AU2019285375A1 AU2019285375A1 (en) 2021-01-21
AU2019285375B2 true AU2019285375B2 (en) 2025-04-17

Family

ID=68841796

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019285375A Active AU2019285375B2 (en) 2018-06-15 2019-06-12 Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane

Country Status (6)

Country Link
US (1) US20210138002A1 (enExample)
EP (1) EP3806879A4 (enExample)
JP (1) JP7385930B2 (enExample)
AU (1) AU2019285375B2 (enExample)
CA (1) CA3103831A1 (enExample)
WO (1) WO2019237152A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024026529A1 (en) * 2022-08-01 2024-02-08 Health Food Symmetry Pty Ltd Preparation for the treatment of non-alcoholic fatty liver disease (nafld)
BE1031643B1 (nl) * 2023-05-26 2025-01-03 Synero Bv Functionele drank alsook werkwijze voor het vervaardigen en stabiliseren hiervan

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014162303A1 (en) * 2013-04-05 2014-10-09 Gratuk Technologies Pty Ltd Use of a dietary fibre supplement in a food formulation
WO2015071811A1 (en) * 2013-11-18 2015-05-21 Kfsu Ltd Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (gord/gerd)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US20080227753A1 (en) * 2007-02-26 2008-09-18 Kun Lian Nano-sized Bagasse Fiber
US9245263B2 (en) * 2009-06-23 2016-01-26 Jwl Ip Holdings Llc Systems and methods for scripted content delivery
KR101857617B1 (ko) 2009-12-22 2018-05-15 프로비 아베 곡물 기저의 분획 및 프로바이오틱을 포함하는 비-발효 조성물 및 그 용도
CN104168779A (zh) 2012-03-05 2014-11-26 格拉图克技术私人有限公司 膳食补充剂
CN103355728A (zh) * 2013-07-01 2013-10-23 福建省农业科学院农业工程技术研究所 一种果汁的固定化半连续乳酸发酵方法
JP5852207B2 (ja) 2013-11-29 2016-02-03 喜信 大城 サトウキビの難消化性食物繊維の製造方法
JP2015202057A (ja) 2014-04-11 2015-11-16 喜信 大城 食物繊維入りヨーグルトの製造方法
JP6306170B2 (ja) * 2014-05-24 2018-04-04 アテリオ・バイオ株式会社 難消化性物質及びその製造方法
AU2015274249B2 (en) * 2014-06-13 2021-12-23 Gratuk Technologies Pty Ltd Dietary supplement
CN104814365A (zh) * 2015-05-29 2015-08-05 郭心仪 鹅饲料的制备方法
CN105685486A (zh) * 2016-01-29 2016-06-22 刘健 一种天然高纤维无臭型牛羊饲料的制备方法
CN106883968A (zh) * 2017-04-24 2017-06-23 贵州省仁怀市茅台镇永泰酒业股份有限公司 一种杨梅果酒生产方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014162303A1 (en) * 2013-04-05 2014-10-09 Gratuk Technologies Pty Ltd Use of a dietary fibre supplement in a food formulation
WO2015071811A1 (en) * 2013-11-18 2015-05-21 Kfsu Ltd Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (gord/gerd)

Also Published As

Publication number Publication date
JP2021527104A (ja) 2021-10-11
CA3103831A1 (en) 2019-12-19
AU2019285375A1 (en) 2021-01-21
EP3806879A1 (en) 2021-04-21
US20210138002A1 (en) 2021-05-13
JP7385930B2 (ja) 2023-11-24
EP3806879A4 (en) 2022-03-09
WO2019237152A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
AU2019285375B2 (en) Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane
Dixit et al. Patents in the field of probiotics, prebiotics, synbiotics: a review
US9655932B2 (en) Composition and method for preventing or treating gout or hyperuricemia
CA2772163C (en) Bifidobacterium longum and functional gi disorders
US11103542B2 (en) Composition and method for maintaining healthy kidney function
JP2009511469A (ja) 脂肪代謝及び肥満に影響を及ぼすプロバイオティクス
CN110325198A (zh) 益生菌在治疗和/或预防银屑病中的用途
US11045509B2 (en) Tributyrin compositions and methods therefor
Mishra et al. Current trends in non-dairy based synbiotics
CA2812909C (en) Compositions and methods for augmenting kidney function
JP5592640B2 (ja) 乳酸菌発酵ローヤルゼリーを含有する抗ストレス剤、その製造方法、視床下部−下垂体−副腎皮質系の活動抑制剤、及び交感神経−副腎髄質系の活動抑制剤
US20250170088A1 (en) Method and composition for improving intestinal microflora
CN100402042C (zh) 增强肾功能的组合物及方法
WO2024055983A1 (zh) 南瓜籽蛋白组合物和其应用
US11179426B2 (en) Composition and method for maintaining healthy kidney function
Li et al. Microencapsulation protected Lactobacillus viability and its activity in modulating the intestinal microbiota in newly weaned piglets
WO2024026529A1 (en) Preparation for the treatment of non-alcoholic fatty liver disease (nafld)
Saxelin et al. Developing a multispecies probiotic combination.
Ankita et al. Role of Probiotic in early weaned piglets
HK40065763A (zh) 产生短链脂肪酸的益生菌菌株和包含该益生菌菌株的组合物
BRPI1003558B1 (pt) Método de fabricação de uma preparação probiótica, formulação probiótica veterrinária e seus usos

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)